151 related articles for article (PubMed ID: 22166746)
21. Nucleoplasm staining patterns and cell cycle-associated expression of Ki-67 in middle ear cholesteatoma.
Raynov AM; Moon SK; Choung YH; Hong SP; Park K
Am J Otolaryngol; 2005; 26(5):296-301. PubMed ID: 16137526
[TBL] [Abstract][Full Text] [Related]
22. [Comparative analysis of the proliferative capacity of cholesteatomas].
Bernal Sprekelsen M; Ebmeyer J; Buchbinder A; Sudhoff H
Acta Otorrinolaringol Esp; 2000 May; 51(4):299-307. PubMed ID: 10984952
[TBL] [Abstract][Full Text] [Related]
23. Cell cycle inhibitory protein p27 in human middle ear cholesteatoma.
Kuczkowski J; Bakowska A; Pawelczyk T; Narozny W; Mikaszewski B
ORL J Otorhinolaryngol Relat Spec; 2006; 68(5):296-301. PubMed ID: 16825801
[TBL] [Abstract][Full Text] [Related]
24. The oncoprotein, gankyrin, is up-regulated in middle ear cholesteatoma.
Kim KH; Lim HJ; Kim YJ; Kim SW; Kim YS; Tian C; Park K; Park TJ; Choung YH
Acta Otolaryngol; 2014 Mar; 134(3):238-43. PubMed ID: 24460153
[TBL] [Abstract][Full Text] [Related]
25. Up-regulation of neutrophil gelatinase-associated lipocalin in cholesteatoma.
Woo HJ; Park JC; Bae CH; Song SY; Lee HM; Kim YD
Acta Otolaryngol; 2009 Jun; 129(6):624-9. PubMed ID: 18720059
[TBL] [Abstract][Full Text] [Related]
26. Using surgical observations of ossicular erosion patterns to characterize cholesteatoma growth.
Maresh A; Martins OF; Victor JD; Selesnick SH
Otol Neurotol; 2011 Oct; 32(8):1239-42. PubMed ID: 21921854
[TBL] [Abstract][Full Text] [Related]
27. [The expression of Ras protein in human middle ear cholesteatoma].
Xu Y; Jin K; Dong W
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Apr; 34(2):74-6. PubMed ID: 12764851
[TBL] [Abstract][Full Text] [Related]
28. Correlation of clinical and surgical findings to histological features (koilocytosis, papillary hyperplasia) suggesting papillomavirus involvement in the pathogenesis of cholesteatoma.
Ferekidis E; Nikolopoulos TP; Yiotakis J; Ferekidou E; Kandiloros D; Papadimitriou K; Tzangaroulakis A
Med Sci Monit; 2006 Sep; 12(9):CR368-71. PubMed ID: 16940929
[TBL] [Abstract][Full Text] [Related]
29. [Immunohistochemical discrimination of aggressivity between the cholesteatoma from different positions].
Ma X; Yu LS; Xia RM
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2006 Aug; 41(8):574-8. PubMed ID: 17039796
[TBL] [Abstract][Full Text] [Related]
30. Follow-up of cholesteatoma surgery: open versus closed tympanoplasty.
Stankovic M
ORL J Otorhinolaryngol Relat Spec; 2007; 69(5):299-305. PubMed ID: 17630475
[TBL] [Abstract][Full Text] [Related]
31. [Markers of epidermal proliferation in middle ear cholesteatoma].
Hassmann-Poznańska E; Skotnicka B; Dziecioł J
Otolaryngol Pol; 2003; 57(4):505-11. PubMed ID: 14587387
[TBL] [Abstract][Full Text] [Related]
32. Increased amphiregulin expression as a biomarker of cholesteatoma activity.
Macias MP; Gerkin RD; Macias JD
Laryngoscope; 2010 Nov; 120(11):2258-63. PubMed ID: 20938960
[TBL] [Abstract][Full Text] [Related]
33. Differential gene expression in cholesteatoma by DNA chip analysis.
Macias JD; Gerkin RD; Locke D; Macias MP
Laryngoscope; 2013 Oct; 123 Suppl S5():S1-21. PubMed ID: 23670528
[TBL] [Abstract][Full Text] [Related]
34. Immune cell profile in invasive cholesteatomas: preliminary findings.
Hussein MR; Sayed RH; Abu-Dief EE
Exp Mol Pathol; 2010 Apr; 88(2):316-23. PubMed ID: 20045407
[TBL] [Abstract][Full Text] [Related]
35. [Is reuse of autologous ear ossicles in cholesteatoma or chronic suppurative otitis media justified?].
Peng JC; Hoppe F
Laryngorhinootologie; 1994 Jul; 73(7):375-80. PubMed ID: 7916783
[TBL] [Abstract][Full Text] [Related]
36. Immunobiological peculiarities of cholesteatoma in children: quantification of epithelial proliferation by MIB1.
Bujía J; Holly A; Antolí-Candela F; Tapia MG; Kastenbauer E
Laryngoscope; 1996 Jul; 106(7):865-8. PubMed ID: 8667984
[TBL] [Abstract][Full Text] [Related]
37. Cholesteatoma epithelium is characterized by increased expression of Ki-67, p53 and p21, with minimal apoptosis.
Huisman MA; De Heer E; Grote JJ
Acta Otolaryngol; 2003 Apr; 123(3):377-82. PubMed ID: 12737294
[TBL] [Abstract][Full Text] [Related]
38. [Role of microvessel density on human middle ear cholesteatoma].
Lin RY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2005 Mar; 40(3):186-9. PubMed ID: 15952567
[TBL] [Abstract][Full Text] [Related]
39. Pathogenesis of attic cholesteatoma: clinical and immunohistochemical support for combination of retraction theory and proliferation theory.
Sudhoff H; Tos M
Am J Otol; 2000 Nov; 21(6):786-92. PubMed ID: 11078064
[TBL] [Abstract][Full Text] [Related]
40. Increased expression of p63 and survivin in cholesteatomas.
Park HR; Min SK; Min K; Jun SY; Seo J; Kim HJ
Acta Otolaryngol; 2009 Mar; 129(3):268-72. PubMed ID: 18615329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
